323 - Chronic Graft-Versus-Host Disease and Disease Status at Relapse as Predictors of Clinical Outcomes in Patients Receiving Azacitidine & Donor Lymphocyte Infusions as Salvage Therapy for Post Allograft Relapse of Myeloid Neoplasms
Publication/Presentation Date
3-2018
Volume
24
Issue
3
First Page
236
Last Page
236
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine, Lehigh Valley Topper Cancer Institute
Document Type
Article
COinS